|Product name||Biotinylated Recombinant Human BCMA Protein|
|Description||Biotinylated Recombinant Human BCMA Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Met1-Ala54 Trimer ) of Human BCMA fused with a His tag and Avi at the C-terminal.|
|Bio-Activity||Immobilized Biotinylated Human BCMA, His Tag at 0.5ug/ml (100ul/Well). Dose response curve for Anti-Human BCMA Ab.with the EC50 of 5.9ng/ml determined by ELISA.|
|Purity||> 95% by Tris-Bis PAGE;> 95% by SEC-HPLC|
|Endotoxin||< 1 EU/μg of the protein by LAL method.|
|Formulation||Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.|
|Synonym||CD269 antigen; CD269; TNFRSF17; B cell maturation antigen; B-cell maturation protein; BCMA; BCMA tumor necrosis factor receptor superfamily member 17; BCMB-cell maturation factor; tumor necrosis factor receptor superfamily; member 17|
|Storage||Store the lyophilized protein at -20°C to -80°C for long term.|
After reconstitution, the protein solution is stable at -20°C for 3 months, at 2-8°C for up to 1 week.
|Reconstitution||Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.|
* For research use only. Not for therapeutic or diagnostic purposes.
Submit your question about RP02287 below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.